2 Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, 14214, USA
A basic metabolic panel, lipid panel, HbA1c, and a thyroid panel give you a reference point
Du J, Wang T, Li Y, Zhou Y, Wang X, Yu X, Ren X, An Y, Wu Y, Sun W, et al
While the overall weight loss was lower in this patient population, the researchers highlighted the importance of these results given the fact that type 2 diabetes and its treatment makes weight loss more difficult
Simply take your next scheduled dose as usual
Fewer options : As a new triple agonist, retatrutide is an option for patients who havent responded positively to other weight loss or diabetes medications